Advanced

Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.

Holm, Karolina LU ; Staaf, Johan LU ; Jönsson, Göran B LU ; Vallon-Christersson, Johan LU ; Gunnarsson, Haukur; Arason, Adalgeir; Magnusson, Linda LU ; Barkardottir, Rosa B; Hegardt, Cecilia LU and Ringnér, Markus LU , et al. (2012) In Breast Cancer Research and Treatment 133(2). p.583-594
Abstract
Amplification of chromosomal region 11q13, containing the cell cycle regulatory gene CCND1, is frequently found in breast cancer and other malignancies. It is associated with the favourable oestrogen receptor (ER)-positive breast tumour phenotype, but also with poor prognosis and treatment failure. 11q13 spans almost 14 Mb and contains more than 200 genes and is affected by various patterns of copy number gains, suggesting complex mechanisms and selective pressure during tumour progression. In this study, we used 32 k tiling BAC array CGH to analyse 94 CCND1-amplified breast tumours from sporadic, hereditary, and familial breast cancers to fine map chromosome 11q13. A set containing 281 CCND1-non-amplified breast tumours was used for... (More)
Amplification of chromosomal region 11q13, containing the cell cycle regulatory gene CCND1, is frequently found in breast cancer and other malignancies. It is associated with the favourable oestrogen receptor (ER)-positive breast tumour phenotype, but also with poor prognosis and treatment failure. 11q13 spans almost 14 Mb and contains more than 200 genes and is affected by various patterns of copy number gains, suggesting complex mechanisms and selective pressure during tumour progression. In this study, we used 32 k tiling BAC array CGH to analyse 94 CCND1-amplified breast tumours from sporadic, hereditary, and familial breast cancers to fine map chromosome 11q13. A set containing 281 CCND1-non-amplified breast tumours was used for comparisons. We used gene expression data to further validate the functional effect of gene amplification. We identified six core regions covering 11q13.1-q14.1 that were amplified in different combinations. The major core contained CCND1, whereas two cores were found proximal of CCND1 and three distal. The majority of the CCND1-amplified tumours were ER-positive and classified as luminal B. Furthermore, we found that CCND1 amplification is associated with a more aggressive phenotype within histological grade 2 tumours and luminal A subtype tumours. Amplification was equally prevalent in familial and sporadic tumours, but strikingly rare in BRCA1- and BRCA2-mutated tumours. We conclude that 11q13 includes many potential target genes in addition to CCND1. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Breast Cancer Research and Treatment
volume
133
issue
2
pages
583 - 594
publisher
Springer
external identifiers
  • WOS:000304610600018
  • PMID:22002566
  • Scopus:84863716004
ISSN
1573-7217
DOI
10.1007/s10549-011-1817-3
language
English
LU publication?
yes
id
3fa21f7d-ea14-472a-b4b2-d7001d973c02 (old id 2200455)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/22002566?dopt=Abstract
date added to LUP
2011-11-02 10:26:21
date last changed
2017-01-01 07:44:38
@article{3fa21f7d-ea14-472a-b4b2-d7001d973c02,
  abstract     = {Amplification of chromosomal region 11q13, containing the cell cycle regulatory gene CCND1, is frequently found in breast cancer and other malignancies. It is associated with the favourable oestrogen receptor (ER)-positive breast tumour phenotype, but also with poor prognosis and treatment failure. 11q13 spans almost 14 Mb and contains more than 200 genes and is affected by various patterns of copy number gains, suggesting complex mechanisms and selective pressure during tumour progression. In this study, we used 32 k tiling BAC array CGH to analyse 94 CCND1-amplified breast tumours from sporadic, hereditary, and familial breast cancers to fine map chromosome 11q13. A set containing 281 CCND1-non-amplified breast tumours was used for comparisons. We used gene expression data to further validate the functional effect of gene amplification. We identified six core regions covering 11q13.1-q14.1 that were amplified in different combinations. The major core contained CCND1, whereas two cores were found proximal of CCND1 and three distal. The majority of the CCND1-amplified tumours were ER-positive and classified as luminal B. Furthermore, we found that CCND1 amplification is associated with a more aggressive phenotype within histological grade 2 tumours and luminal A subtype tumours. Amplification was equally prevalent in familial and sporadic tumours, but strikingly rare in BRCA1- and BRCA2-mutated tumours. We conclude that 11q13 includes many potential target genes in addition to CCND1.},
  author       = {Holm, Karolina and Staaf, Johan and Jönsson, Göran B and Vallon-Christersson, Johan and Gunnarsson, Haukur and Arason, Adalgeir and Magnusson, Linda and Barkardottir, Rosa B and Hegardt, Cecilia and Ringnér, Markus and Borg, Åke},
  issn         = {1573-7217},
  language     = {eng},
  number       = {2},
  pages        = {583--594},
  publisher    = {Springer},
  series       = {Breast Cancer Research and Treatment},
  title        = {Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.},
  url          = {http://dx.doi.org/10.1007/s10549-011-1817-3},
  volume       = {133},
  year         = {2012},
}